Pharma News

Strides receives USFDA approval for Butalbital, Acetaminophen, and Caffeine Tablets

  • Posted on: 22 September 2020
  • By: PharmaTutor News

Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Butalbital, Acetaminophen, and Caffeine Tablets USP, 50 mg/325 mg/40 mg from the United States Food & Drug Administration (USFDA).

CDSCO developed draft guidelines for vaccine development

  • Posted on: 22 September 2020
  • By: admin

CDSCO (Central Drugs Standard Control Organization) has developed draft guidelines for vaccine development in light of the present pandemic situation in the country. Development of vaccine is a complex activity which involves multidisciplinary research and generation of adequate laboratory, nonclinical and clinical data to ensure their safety, efficacy and quality. India is one of the major producers of vaccines in the world which cater the major portion of requirements of many vaccines globally.

Roche presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer

  • Posted on: 21 September 2020
  • By: PharmaTutor News

Roche announced that it presented the latest results from three Phase III studies from the Tecentriq® (atezolizumab) clinical development programme in triple-negative breast cancer (TNBC) at the European Society for Medical Oncology (ESMO) Virtual Congress 2020.

Pages